Start-Up Previews (09/00)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, New Approaches to Neurodegenerative Disorders, features profiles of Active Pass Pharmaceuticals Inc., Aegera Therapeutics Inc., Panacea Pharmaceuticals Inc. and Proteotech Inc. Plus these selected Start-Ups across Health Care: Amicas Inc., CFY Biomedicals Inc., MDISource and Visco Technologies Inc.
You may also be interested in...
INFOGRAPHIC: In 2019, 10 blockbuster medicines booked combined sales of $92.5bn. This infographic examines those drugs that commanded the greatest revenues globally, and answers some key questions. Which therapeutic areas include the most lucrative blockbusters? Which companies enjoyed their spoils? And which drugs were new to the top 10 last year? It also takes a look at the position of these products on the all-important US market.
Unique Device Identification (UDI) is key to better transparency and traceability in the EU. But this UDI is new to EU medtech manufacturers and complex. The commission has published some helpful pointers.
Pricing set somewhere down the middle as Moderna reaches deal with US government on initial supplies of its mRNA coronavirus vaccine.